Log in to save to my catalogue

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques...

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7ddec5d298994b9fb951ab9ada5f2108

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

About this item

Full title

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

Publisher

London: Nature Publishing Group UK

Journal title

Communications medicine, 2023-05, Vol.3 (1), p.75-16, Article 75

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
Since the beginning of the COVID-19 pandemic, several variants of concern (VOC) have emerged for which there is evidence of an increase in transmissibility, more severe disease, and/or reduced vaccine effectiveness. Effective COVID-19 vaccine strategies are required to achieve broad protective immunity against current and future VOC.<...

Alternative Titles

Full title

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7ddec5d298994b9fb951ab9ada5f2108

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7ddec5d298994b9fb951ab9ada5f2108

Other Identifiers

ISSN

2730-664X

E-ISSN

2730-664X

DOI

10.1038/s43856-023-00302-z

How to access this item